Translocation (12;14) in lipoma: A case report and review of the literature

Cancer Genetics and Cytogenetics

Volumn 103, Issue 1, 1998, Pages 59-61

  Dong, Shu Ying ^a   Morgan, Rod ^a   Stone, John ^a   Meloni Ehrig, Aurelia M ^b   Chen, Zhong ^a   Malawer, Martin M ^c   Sandberg, Avery A ^a,d  

^a GENZYME GENETICS   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c WASHINGTON CANCER INSTITUTE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARM MUSCLE; ARTICLE; CASE REPORT; CHROMOSOME 12; CHROMOSOME 14; CHROMOSOME TRANSLOCATION; CYTOGENETICS; HUMAN; KARYOTYPE; LIPOMA; MALE; PRIORITY JOURNAL; SHOULDER GIRDLE; TUMOR LOCALIZATION;

CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 14; HUMANS; KARYOTYPING; LIPOMA; MALE; MIDDLE AGED; MUSCLE NEOPLASMS; SHOULDER; TRANSLOCATION, GENETIC;

EID: 0032078038     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00344-0     Document Type: Article

References (13)

1. 1. Enzinger FM, Weiss SW (1995): Soft Tissue Tumors, 3rd Ed. Mosby-Year Book, Inc., St. Louis, pp. 384-395.
2. 2. Sandberg AA, Bridge JA (1994): The Cytogenetics of Bone and Soft Tissue Tumors. RG Landes Co., Georgetown, pp. 150-188.
3. 3. Limon J, Dal Clin P, Sandberg AA (1986): Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 23:305-313.
4. 4. Seabright M (1971): Rapid banding technique for human chromosomes. Lancet 2:971-972.
5. 5. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
6. 6. Sreekantaiah C, Leong SPL, Karakousis CP, McGee DL, Rappaport WD, Villar HV, Neal D, Fleming S, Wankel A, Herrington PN, Carmona R, Sandberg AA (1991): Cytogenetic profile of 109 lipomas. Cancer Res 51:422-433.
7. 7. Mrózek K, Karakousis CP, Bloomfield CD (1993): Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: Localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3. Cancer Res 53:1670-1675.
8. 8. Mandahl N, Hoglund M, Mertens F, Rydholm A, Willén H, Brosjo O (1994): Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosom Cancer 9:207-215.
9. 9. Hu J, Surti U, Tobon H (1992): Cytogenetic analysis of a uterine lipoleiomyoma. Cancer Genet Cytogenet 62:200-202.
10. 10. Heim S, Nilbert M, Vanni R, Flodérus UM, Mandahl N, Lundgren S, Lecca U, Mitelman F (1988): A specific translocation, t(12;14)(q14-15;q23-24), characterizes a subgroup of uterine leiomyomas. Cancer Genet Cytogenet 32:13-17.
11. 11. Vanni R, Lecca U, Faa G (1991): Uterine leiomyoma cytogenetics: Report of forty cases. Cancer Genet Cytogenet 53:247-256.
12. 12. Meloni AM, Surti U, Contento AM, Devare J, Sandberg AA (1992): Uterine leiomyomas: Cytogenetic and histologic profile. Obstet Gynecol 80:209-217.
13. 13. Fejzo MS, Ashar HR, Krauter KS, Powell WL, Rein MS, Weremowicz S, Yoon S-J, Kucherlapati RS, Chada K, Morton CC (1996): Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas. Genes Chromosom Cancer 17:1-6.